← Leaderboards
Elizabeth L. Hohmann
Massachusetts General Hospital
$6,946,802
Attributed
$7,169,275
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,169,275 · 9
By mechanism
R01$4,274,304 · 3
M01$2,400,295 · 4
R21$444,946 · 1
S07$49,730 · 1
Top collaborators
- Bernd G. Schnabl2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Edward T. Ryan$44,052,519
- Bobby Joseph Cherayil$7,100,760
- Richelle C Charles$6,402,547
- Jason B Harris$16,544,490
- Janne Johannes Nappi$1,542,510
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectAttenuated MicroorganismDrug Screening /EvaluationVector VaccineSalmonella VaccinesSalmonella TyphiVirulenceActive ImmunizationHeterophile AntigensListeriaLaboratory MouseClinical TrialsBacterial VaccinesImmunizationChimeric ProteinsVirus AntigenTyphoidsClinical Trial Phase IOral AdministrationGenetic StrainFeces AnalysisEscherichia ColiEnzyme Linked Immunosorbent Assay
Grant awards (28)
Fecal microbiota transplantation for auto-brewery syndrome$195,906
R21 · FY2025 · AA
Fecal microbiota transplantation for auto-brewery syndrome$249,040
R21 · FY2024 · AA
Collaborative IRB Review and Ethical/Educational Exchange - Boston/Durban$49,730
S07 · FY2010 · TW · contact PI
Human studies of Listeria monocytogenes vectors$26,370
R01 · FY2008 · AI · contact PI
Human Studies of Attenuated Salmonella Vectors$491,067
R01 · FY2007 · AI · contact PI
Human Studies of Attenuated Salmonella Vectors$517,568
R01 · FY2006 · AI · contact PI
SAFETY AND IMMUNOGENICITY OF ATTENUATED SALMONELLA TYPHIMURIUM$409,062
M01 · FY2006 · RR · contact PI
Human studies of Listeria monocytogenes vectors$384,556
R01 · FY2006 · AI · contact PI
SAFETY AND IMMUNOGENICITY OF ATTENUATED SALMONELLA TYPHIMURIUM$786,050
M01 · FY2005 · RR
Human Studies of Attenuated Salmonella Vectors$489,596
R01 · FY2005 · AI
Human studies of Listeria monocytogenes vectors$393,810
R01 · FY2005 · AI
Human studies of Listeria monocytogenes vectors$393,810
R01 · FY2004 · AI
Human studies of Listeria monocytogenes vectors$393,810
R01 · FY2003 · AI
Human studies of Listeria monocytogenes vectors$393,810
R01 · FY2002 · AI
PHOP/PHOQ DELETED S TYPHI VACCINE STRAINS$271,122
R01 · FY2002 · AI
Safety &Shedding of Attenuated Listeria Vaccine Vectors$200,768
M01 · FY2002 · RR
Safety &Shedding of Attenuated Listeria Vaccine Vectors$200,768
M01 · FY2002 · RR
SAFETY AND IMMUNOGENICITY OF TY800 CARRYING HETEROLOGOUS ANTIGENS$200,768
M01 · FY2002 · RR
SAFETY AND IMMUNOGENICITY OF TY800 CARRYING HETEROLOGOUS ANTIGENS$200,768
M01 · FY2002 · RR
PHOP/PHOQ DELETED S TYPHI VACCINE STRAINS$263,225
R01 · FY2001 · AI
SAFETY AND IMMUNOGENICITY OF TY800 CARRYING HETEROLOGOUS ANTIGENS$200,768
M01 · FY2001 · RR
Safety &Shedding of Attenuated Listeria Vaccine Vectors$200,768
M01 · FY2001 · RR
SAFETY AND IMMUNOGENICITY OF TY800 CARRYING HETEROLOGOUS ANTIGENS$0
M01 · FY2001 · RR
Safety &Shedding of Attenuated Listeria Vaccine Vectors$0
M01 · FY2001 · RR
PHOP/PHOQ DELETED S TYPHI VACCINE STRAINS$255,560
R01 · FY2000 · AI
SAFETY AND IMMUNOGENICITY OF TY800 CARRYING HETEROLOGOUS ANTIGENS$575
M01 · FY2000 · RR
Safety &Shedding of Attenuated Listeria Vaccine Vectors$0
M01 · FY2000 · RR
SAFETY AND IMMUNOGENICITY OF TY800 CARRYING HETEROLOGOUS ANTIGENS$0
M01 · FY2000 · RR